NCT03114098View on ClinicalTrials.gov

Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 7, 2016

Primary Completion Date

December 12, 2018

Study Completion Date

January 31, 2019

Conditions
Drug ResistancePsychotropic Drugs
Interventions
OTHER

gene abnormalities

A salivary sample (2 ml sample) Blood sampling will be performed to assess treatment tolerance (6 ml)

Trial Locations (1)

06200

Fondation Lenval Hôpitaux Pédiatriques de Nice CHU-LENVAL, Nice

All Listed Sponsors
lead

Fondation Lenval

OTHER

NCT03114098 - Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs | Biotech Hunter | Biotech Hunter